comparemela.com
Home
Live Updates
Hyperlipidemia - Breaking News
Pages:
7
8
9
10
11
12
13
Latest Breaking News On - Hyperlipidemia - Page 6 : comparemela.com
Real-World Data on Achieving LDL Thresholds
Mary McGowan, MD, FNLA, discusses real-world data from the Family Heart Database on achieving LDL-C thresholds.
United states
Mary mcgowan
Keithc ferdinand
Family heart foundation
A family heart foundation
Family heart
Family heart database
Cardiovascular disease
Ldl c
Ldlc levels
Statin combination therapy
Combination lipid lowering therapise
Kansas City researchers find breakthrough in pancreatic cancer treatment
Pancreatic cancer has one of the lowest five year survival rates - roughly 12%, according to the Pancreatic Cancer Action Network.
United states
Kansas city
Ehab sarsour
Katiana hebbert
Rebecca gannon
Pancreatic cancer action network
University of iowa
International congress
Emergency department
Radiation research
University of california
Kansas city university
Pancreatic cancer action
Kansas city not
Pancreatic cancer
Ive year survival rates
New Guidance in Lowering LDL-C
A panel of cardiologists discuss the key updates from the 2022 ACC Expert Consensus Decision Pathway on the role of nonstatin therapies for LDL-C lowering in the management of atherosclerotic cardiovascular disease risk.
United states
Payal kohli
Christiem ballantyne
Keithc ferdinand
Erind michos
Cardiology expert consensus decision pathway
Bogalusa heart study
Consensus decision pathway
South asian
Ldl c
Cardiovascular disease
Cardiovascular risk
Primary prevention
Secondary prevention
High risk
Lifetime risk of ascvd
LDL-C and Cardiovascular Disease Risk
Expert cardiologists discuss the various lines of evidence that have shown a causative effect of LDL-C in the development of atherosclerosis.
United states
New orleans
Keithc ferdinand
Erin michos
Mary mcgowan
Christie ballantyne
Christiem ballantyne
Geralds berenson
Payal kohli
Erind michos
Family heart foundation
Section of cardiovascular research
Hcplive peer exchange
Johns hopkins university
Im at dartmouth medical school
University of colorado
Nilotinib Linked to Metabolic Syndrome and CVD in CML
Investigators suggest using other TKIs in patients with preexisting diabetes and hyperlipidemia.
Chang gung memorial hospital
Taoyuan xian
Jiayi shi
Republic of china
Taiwan general
Chang gung medical foundation
Cih en huang
Chronic myelogenous leukemia
Small molecule inhibitor
Cardiometabolic risk
Ipid management
Tyrosine kinase inhibitor
Metabolic syndrome
Biologic therapy
Antineoplastic drug
Nti cancer agents
vimarsana © 2020. All Rights Reserved.